Prostaglandin E 2 suppresses allergic sensitization and lung inflammation by targeting the E prostanoid 2 receptor on T cells
暂无分享,去创建一个
M. Peters-Golden | B. Moore | N. Lukacs | K. Okunishi | Z. Zasłona | Aronoff | E. Bourdonnay | Racquel | Domingo-Gonzalez | M. David | Z. Zaslona
[1] Chunli Feng,et al. Prostaglandin E2 deficiency uncovers a dominant role for thromboxane A2 in house dust mite-induced allergic pulmonary inflammation , 2012, Proceedings of the National Academy of Sciences.
[2] B. Koller,et al. Prostaglandin E2 Produced by the Lung Augments the Effector Phase of Allergic Inflammation , 2012, The Journal of Immunology.
[3] B. Sastre,et al. Role of PGE2 in Asthma and Nonasthmatic Eosinophilic Bronchitis , 2012, Mediators of inflammation.
[4] D. Aronoff,et al. Prostaglandin E2 restrains macrophage maturation via E prostanoid receptor 2/protein kinase A signaling. , 2012, Blood.
[5] M. Fresno,et al. Prostaglandin E2 and T cells: friends or foes? , 2011, Immunology and cell biology.
[6] M. Peters-Golden,et al. Airway remodeling in murine asthma correlates with a defect in PGE2 synthesis by lung fibroblasts. , 2011, American journal of physiology. Lung cellular and molecular physiology.
[7] A. Amberbir,et al. Frequent Use of Paracetamol and Risk of Allergic Disease Among Women in an Ethiopian Population , 2011, PloS one.
[8] C. Coban,et al. Silica crystals and aluminum salts regulate the production of prostaglandin in macrophages via NALP3 inflammasome-independent mechanisms. , 2011, Immunity.
[9] L. Pujols,et al. Activity of the cyclooxygenase 2-prostaglandin-E prostanoid receptor pathway in mice exposed to house dust mite aeroallergens, and impact of exogenous prostaglandin E2 , 2009, Journal of Inflammation.
[10] V. Backer,et al. Regular use of non‐steroidal anti‐inflammatory drugs increases the risk of adult‐onset asthma: a population‐based follow‐up study , 2009, The clinical respiratory journal.
[11] M. Okano,et al. Prostaglandin E(2) suppresses staphylococcal enterotoxin-induced eosinophilia-associated cellular responses dominantly through an E-prostanoid 2-mediated pathway in nasal polyps. , 2009, The Journal of allergy and clinical immunology.
[12] J. Roca‐Ferrer,et al. Subcutaneous Prostaglandin E2 Restrains Airway Mast Cell Activity in vivo and Reduces Lung Eosinophilia and Th2 Cytokine Overproduction in House Dust Mite-Sensitive Mice , 2009, International Archives of Allergy and Immunology.
[13] M. Peters-Golden,et al. Efferocytosis impairs pulmonary macrophage and lung antibacterial function via PGE2/EP2 signaling , 2009, The Journal of experimental medicine.
[14] G. Sturm,et al. Prostaglandin E2 Inhibits Eosinophil Trafficking through E-Prostanoid 2 Receptors1 , 2008, The Journal of Immunology.
[15] A. Nials,et al. Mouse models of allergic asthma: acute and chronic allergen challenge , 2008, Disease Models & Mechanisms.
[16] R. Peebles,et al. Cyclooxygenase Inhibition during Allergic Sensitization Increases STAT6-Independent Primary and Memory Th2 Responses1 , 2008, The Journal of Immunology.
[17] G. FitzGerald,et al. Prostaglandin I2-IP Signaling Blocks Allergic Pulmonary Inflammation by Preventing Recruitment of CD4+ Th2 Cells into the Airways in a Mouse Model of Asthma1 , 2007, The Journal of Immunology.
[18] J. Frelinger,et al. Francisella tularensis-Infected Macrophages Release Prostaglandin E2 that Blocks T Cell Proliferation and Promotes a Th2-Like Response1 , 2007, The Journal of Immunology.
[19] M. Nishibori,et al. E prostanoid 2 (EP2)/EP4‐mediated suppression of antigen‐specific human T‐cell responses by prostaglandin E2 , 2006, Immunology.
[20] J. Morrow,et al. Allergen-induced airway hyperresponsiveness mediated by cyclooxygenase inhibition is not dependent on 5-lipoxygenase or IL-5, but is IL-13 dependent. , 2006, Journal of immunology.
[21] S. Narumiya,et al. Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3 , 2005, Nature Immunology.
[22] Hiroshi Tanaka,et al. Prostaglandin E2 receptor selective agonists E-prostanoid 2 and E-prostanoid 4 may have therapeutic effects on ovalbumin-induced bronchoconstriction. , 2005, Chest.
[23] H. Allmers. Frequent acetaminophen use and allergic diseases: is the association clear? , 2005, The Journal of allergy and clinical immunology.
[24] K. Yamagata,et al. Augmentation of allergic inflammation in the airways of cyclooxygenase‐2‐deficient mice , 2005, Respirology.
[25] D. Aronoff,et al. Cutting Edge: Macrophage Inhibition by Cyclic AMP (cAMP): Differential Roles of Protein Kinase A and Exchange Protein Directly Activated by cAMP-11 , 2005, The Journal of Immunology.
[26] J. Morrow,et al. Cyclooxygenase Inhibition Augments Allergic Inflammation through CD4-Dependent, STAT6-Independent Mechanisms1 , 2005, The Journal of Immunology.
[27] T. Nakajima,et al. Polymorphisms in the prostaglandin E2 receptor subtype 2 gene confer susceptibility to aspirin-intolerant asthma: a candidate gene approach. , 2004, Human molecular genetics.
[28] D. Aronoff,et al. Prostaglandin E2 Inhibits Alveolar Macrophage Phagocytosis through an E-Prostanoid 2 Receptor-Mediated Increase in Intracellular Cyclic AMP12 , 2004, The Journal of Immunology.
[29] Lauren Cohn,et al. Asthma: mechanisms of disease persistence and progression. , 2004, Annual review of immunology.
[30] J. Regan. EP2 and EP4 prostanoid receptor signaling. , 2003, Life sciences.
[31] J. Morrow,et al. Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor. , 2003, The Journal of clinical investigation.
[32] Lawrence J. Marnett,et al. Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H2 synthases , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[33] J. Morrow,et al. Selective cyclooxygenase-1 and -2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in mice. , 2002, American journal of respiratory and critical care medicine.
[34] B. Koller,et al. Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse. , 2001, The Journal of clinical investigation.
[35] J. Harton,et al. Downregulation of CIITA Function by Protein Kinase A (PKA)-Mediated Phosphorylation: Mechanism of Prostaglandin E, Cyclic AMP, and PKA Inhibition of Class II Major Histocompatibility Complex Expression in Monocytic Lines , 2001, Molecular and Cellular Biology.
[36] B. Graham,et al. Cyclooxygenase inhibition increases interleukin 5 and interleukin 13 production and airway hyperresponsiveness in allergic mice. , 2000, American journal of respiratory and critical care medicine.
[37] J. Murray,et al. Prostaglandin E(2) decreases allergen-stimulated release of prostaglandin D(2) in airways of subjects with asthma. , 2000, American journal of respiratory and critical care medicine.
[38] D. Zeldin,et al. Allergic lung responses are increased in prostaglandin H synthase-deficient mice. , 1999, The Journal of clinical investigation.
[39] Mark A. Magnuson,et al. Salt–sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor , 1999, Nature Medicine.
[40] H. Karahashi,et al. Characterization of the LPS-stimulated expression of EP2 and EP4 prostaglandin E receptors in mouse macrophage-like cell line, J774.1. , 1998, Biochemical and biophysical research communications.
[41] Richard A Flavell,et al. The Transcription Factor GATA-3 Is Necessary and Sufficient for Th2 Cytokine Gene Expression in CD4 T Cells , 1997, Cell.
[42] J. Thompson,et al. Inhaled misoprostol blocks guinea pig antigen-induced bronchoconstriction and airway inflammation. , 1996, American journal of respiratory and critical care medicine.
[43] M. Kaplan,et al. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. , 1996, Immunity.
[44] R. M. Refini,et al. Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma. , 1996, American journal of respiratory and critical care medicine.
[45] M. Yacoub,et al. 8-Epi-PGF2 alpha, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro. , 1996, American journal of respiratory and critical care medicine.
[46] L. Mastalerz,et al. Protective and bronchodilator effects of prostaglandin E and salbutamol in aspirin-induced asthma. , 1996, American journal of respiratory and critical care medicine.
[47] C. Parker,et al. Suppression of IL-4 Production in Murine Lymphocytes by Orally Effective Prostaglandin E(1) Analogs. , 1995, American journal of therapeutics.
[48] A. Szczeklik. Prostaglandin E2 and aspirin-induced asthma , 1995, The Lancet.
[49] I. Pavord,et al. Bronchoprotective role for endogenous prostaglandin E2 , 1995, The Lancet.
[50] P. O'Byrne,et al. Effect of inhaled PGE2 on exercise-induced bronchoconstriction in asthmatic subjects. , 1994, American journal of respiratory and critical care medicine.
[51] I. Pavord,et al. Effect of inhaled prostaglandin E2 on allergen-induced asthma. , 1993, The American review of respiratory disease.
[52] F. Paliogianni,et al. Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2R alpha gene expression at multiple levels. , 1992, Journal of immunology.
[53] M. Betz,et al. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. , 1991, Journal of immunology.
[54] T. Gettys,et al. Activation of the cAMP cascade inhibits an early event involved in murine macrophage Ia expression. , 1990, The Journal of biological chemistry.
[55] K. Asano,et al. Role of prostaglandin D(2) and its receptors in the pathophysiology of asthma. , 2008, Allergology international : official journal of the Japanese Society of Allergology.
[56] P. O'Byrne,et al. Protective effects of inhaled PGE2 on allergen-induced airway responses and airway inflammation. , 1999, American journal of respiratory and critical care medicine.